Filing Details

Accession Number:
0000950170-24-016669
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-16 20:35:42
Reporting Period:
2024-02-16
Accepted Time:
2024-02-16 20:35:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1858848 Tenaya Therapeutics Inc. TNYA Biological Products, (No Disgnostic Substances) (2836) 813789973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1868494 Whittemore Tingley C/O Tenaya Therapeutics, Inc.
171 Oyster Point Blvd., 5Th Floor
South San Francisco CA 94080
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-02-16 6,500 $5.86 73,534 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
  2. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $5.61 to $6.15. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. Includes 48,750 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 3,597 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on December 10, 2023.